Front Line Genomics invites you to their event
About this event
Oncological care increasingly relies on molecular tumour characterisation techniques to enhance patient outcomes. However, the clinical utility of some of these methods remains uncertain, potentially affecting their integration into healthcare systems.
With all these new advancements, it can be challenging to stay up to date on the clinical applications and future prospects of these precision oncology techniques.
Join us for our latest 3-part webinar series, Molecular Analysis for Precision Oncology ONLINE, where we’ll hear insights from nine leading experts in the cancer genomics field, covering cutting-edge tumour characterisation techniques and their clinical applications.
By registering for this webinar, you will:
**Please note that by registering for one webinar in the series, you will automatically be registered for all subsequent webinars in the 3 part series**
Tuesday 16th April, 3pm BST/ 4pm CST/ 10am EDT
In this webinar, we will explore the role of genomics in cancer detection, diagnosis and tumour characterisation, and its impact on oncological care.
Our speakers will discuss germline and somatic gene testing, the potential of liquid biopsies in early cancer detection, and the transformative capability of these methods in personalised cancer treatments.
Talk 1: Challenges and Opportunities for Implementing Liquid Biopsies into Routine Clinical Diagnostics
– Elif Dagdan, Director, Center for Medical Genetics Bochum Germany
Talk 2: Implementation of HRD testing for Precision Oncology
– Katya Mokretar, Deputy Operations Lead Molecular Oncology, Synnovis
Tuesday 23rd April, 3pm BST/ 4pm CST/ 10am EDT
Sponsored by Nonacus
Precision oncology methods can now be used at every point of the typical patient pathway, from diagnosis to disease progression. Molecular tools are now being used to enable clinicians to monitor progression, predict relapse and metastasis, and change the course of clinical care in line with these findings.
In this webinar, we will discover how molecular cancer testing is shaping our understanding of cancer evolution, how this aids clinical decision making, and what future developments we can expect in the coming years.
Talk 1: Molecular Characterisation of Ovarian Cancers & Patient Stratification for Precision Oncology
– Robb Hollis, Scientist at CRUK Scotland Centre, University of Edinburgh
Talk 2: GALEAS: Precision Diagnostics Guiding Clinical Decisions- From Solid Tumour to Liquid Biopsy
– Katie Shepherd, Clinical Specialist, Nonacus
Talk 3: Genomic Technologies That Are Shaping Clinical Cancer Care in the NHS
– Gareth Gerrard, Clinical Scientist and Scientific Lead for Cancer Genomics (South East Genomic Laboratory Hub), Guy's and St Thomas' NHS Foundation Trust
Talk 4: Patient Stratification & Precision Medicine Supported by Liquid Biopsies
– Simon Heeke, Liquid Biopsy Translational Working Group Leader, Department of Thoracic Head/ Neck Medical Oncology, MD Anderson Cancer Center
Tuesday 30th April, 3pm BST/ 4pm CST/ 10am EDT
Cancer has historically been the prime example of a disease that benefits from precision medicine approaches, and now we’re seeing progress in integrating these new technologies into the cancer treatment pathway.
This webinar will focus on how precision oncology technologies are translating from research to the clinic, and what challenges we must overcome before these techniques become routine. It will also showcase how the management of cancer is evolving for certain types of malignancies, and what you can expect to see becoming standard practice in healthcare services going forward.
Talk 1: Optimizing Urinary Proteomes as a Liquid Biopsy for Prostate Cancer
– Thomas Kislinger, Professor, University of Toronto
Talk 2: Dynamic Precision Medicine: A New Approach to Therapy Resistance
– Robert Beckman, Professor of Oncology and of Biostatistics, Bioinformatics, and Biomathematics, Georgetown University Medical Center
Talk 3: Circulating Tumor Cells as a Non-Invasive Glioblastoma Approach to Study Recurrence Events and Develop a Challenging Diagnostic Tool
– Francesca Lessi, Researcher, Fondazione Pisana per la Scienza
Hosted by
Front Line Genomics is a genomics-focused media company, with a social mission to deliver the benefits of genomics to patients faster. We organise the Festival of Genomics, digital events and webinars. We also produce reports and operate a content-rich website.
